A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck.
Original Source
Read the full article at Washingtontimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.